RE:RE:News required to move price upwardsWell, if the plant is not ready to produce Coactiv+ as we speak then it is a very poorly execute process. The plant should have been up and ready to produce as soon as the FDA approval was granted. KNE should have been reporting sales in Q3, they didn't so, now the market is waiting for them to report, at a minimum, orders in Q4. Shipment in Q1 2024 will be fine but they need to show that their is some enthusiasm for their product south of the border.
Where did you get that the DispoersinB trail was started? Well, if you know good for you but, so far there is no official announcement from Kane so, I still think that all trials related to DispersinB are still in waiting/negotiating mode, including the UofMiami trials which was suppose to be started in Q3.
If, as you said, the trials have started for DispersinB then, KNE is doing a very poor communication job with the investment community.
P.S. Did you know that they are working on a re-branding of the Coactiv+ brand? If not, you're not on top of it my friend , if you are, well, you must have been in touch with management lately...
GLTA